Inflammation meets sensitization--an explanation for spontaneous nociceptor activity?

Area of Science:

• Neuroscience
• Pain Research
• Dermatology

Background:

• Anti-nerve growth factor (anti-NGF) therapy offers analgesia for chronic inflammatory pain but does not reduce inflammation.
• Ongoing pain from inflammatory mediators may be exacerbated by long-term nociceptor sensitization.

Purpose of the Study:

• To investigate the combined effects of NGF-induced sensitization and UV-B induced inflammation on pain perception in human volunteers.
• To determine if NGF sensitization influences the development of spontaneous pain and hyperalgesia during inflammation.

Main Methods:

• Human volunteers received NGF sensitization 3 weeks prior to controlled UV-B irradiation.
• Pain intensity, hyperalgesia to mechanical and thermal stimuli, and spontaneous pain were assessed using Visual Analog Scale (VAS).
• Evaluated additive and supra-additive effects of combined NGF and UV-B treatments compared to single treatments.

Main Results:

• UV-B irradiation of NGF-sensitized skin intensified pre-existing hyperalgesia and induced spontaneous pain in approximately 70% of subjects.
• Hyperalgesia to mechanical impact and heat was additive, while responses to tonic mechanical pressure and pinprick showed supra-additive increases.
• Supra-additive effects diminished within 24 hours, though heat sensitization persisted; spontaneous pain and hyperalgesia coexisted but did not strongly correlate.

Conclusions:

• NGF sensitizes nociceptive endings, enabling inflammatory mediators to provoke spontaneous pain.
• Neuronal sensitization and the level of inflammation are distinct therapeutic targets for managing chronic inflammatory pain.
• Findings support targeting both NGF-mediated sensitization and inflammatory pathways for comprehensive pain relief.